Technosphere: new drug delivery system for inhaled insulin

  • Sarala N
  • Bengalorkar G
  • Bhuvana K
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Injection has long since been a barrier to insulin use. However, previous attempts to produce an inhaled insulin have met with difficulty. Technosphere insulin is a new system for delivery of inhaled insulin and is currently under review by the FDA. In this Drug profile, the authors discuss the technology and review the clinical data relating to its efficacy and adverse effects. Copyright © 2012 John Wiley & Sons, Ltd.

Cite

CITATION STYLE

APA

Sarala, N., Bengalorkar, G., & Bhuvana, K. (2012). Technosphere: new drug delivery system for inhaled insulin. Future Prescriber, 13(1), 14–16. https://doi.org/10.1002/fps.90

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free